Hypoparathyroidism Potentiates Cardiovascular Complications through Disturbed Calcium Metabolism: Possible Risk of Vitamin D3 Analog Administration in Dialysis Patients with End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|84|1|13-20

ISSN： 1660-8151

Source： Nephron, Vol.84, Iss.1, 2000-01, pp. : 13-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gender-Dependent Impact of Risk Factors for Cardiovascular and Non-Cardiovascular Mortality in End-Stage Renal Disease Patients on Haemodialysis

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 5, 2008-11 ,pp. : 360-366

Karger

Access to resources Recommend Favorite

Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 4, 2017-03 ,pp. : 338-345

Karger

Access to resources Recommend Favorite

Nocturnal Hypoxemia: A Neglected Cardiovascular Risk Factor in End-Stage Renal Disease?

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 120-123

Karger

Access to resources Recommend Favorite

Endothelial Damage, Asymmetric Dimethylarginine and Cardiovascular Risk in End-Stage Renal Disease

By  

Blood Purification, Vol. 20, Iss. 5, 2002-08 ,pp. : 469-472

Karger

Access to resources Recommend Favorite

Vitamin K Antagonists Predispose to Calciphylaxis in Patients with End-Stage Renal Disease

By  

Nephron, Vol. 129, Iss. 3, 2015-02 ,pp. : 197-201

Karger

Access to resources Recommend Favorite